Stockscreener 앱 받기
125.46
1.77%
2.18
시장 영업 전:
125.37
-0.09
-0.07%
전일 마감가:
$123.28
열려 있는:
$123.47
하루 거래량:
4.76M
Relative Volume:
0.77
시가총액:
$218.16B
수익:
$43.84B
순이익/손실:
$13.90B
주가수익비율:
15.74
EPS:
7.9725
순현금흐름:
$6.92B
1주 성능:
+0.30%
1개월 성능:
-2.61%
6개월 성능:
-8.05%
1년 성능:
+10.19%
1일 변동 폭
$122.91
$125.58
1주일 범위
$120.70
$125.58
52주 변동 폭
$110.86
$140.84
애보트 래버러토리스 Stock (ABT) Company Profile
명칭
Abbott Laboratories
전화
(224) 667-6100
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
ABT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-10 | 개시 | The Benchmark Company | Buy |
| 2025-07-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-06-16 | 개시 | Leerink Partners | Market Perform |
| 2024-10-08 | 개시 | Oppenheimer | Outperform |
| 2024-09-19 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-21 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 재확인 | Barclays | Overweight |
| 2023-04-20 | 재확인 | Bernstein | Outperform |
| 2023-04-20 | 재확인 | JP Morgan | Overweight |
| 2023-04-20 | 재확인 | Raymond James | Outperform |
| 2023-04-20 | 재확인 | UBS | Buy |
| 2023-04-20 | 재확인 | Wolfe Research | Underperform |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-10-26 | 개시 | Mizuho | Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-27 | 재확인 | Credit Suisse | Outperform |
| 2022-01-27 | 재확인 | Morgan Stanley | Overweight |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | UBS | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-27 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-01-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-06-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-02-07 | 재확인 | BofA/Merrill | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-11-30 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-01-30 | 재확인 | Citigroup | Neutral |
| 2018-01-25 | 재확인 | Stifel | Buy |
| 2018-01-25 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-10-19 | 재확인 | Stifel | Buy |
모두보기
애보트 래버러토리스 주식(ABT)의 최신 뉴스
Rep. Julie Johnson Sells Abbott Laboratories (NYSE:ABT) Stock - MarketBeat
Texas Permanent School Fund Corp Sells 65,976 Shares of Abbott Laboratories $ABT - MarketBeat
Stance Capital LLC Makes New $1.30 Million Investment in Abbott Laboratories $ABT - MarketBeat
Prostate Cancer Diagnostics Market Is Going to Boom |• Abbott • Siemens - openPR.com
Corient Private Wealth LLC Increases Holdings in Abbott Laboratories $ABT - MarketBeat
Caldwell Trust Co Takes Position in Abbott Laboratories $ABT - MarketBeat
17,830 Shares in Abbott Laboratories $ABT Bought by B. Riley Wealth Advisors Inc. - MarketBeat
Abbott Laboratories Strengthens Shareholder Returns Amid Strategic Acquisition - AD HOC NEWS
Abbott Laboratories (ABT) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025 - ts2.tech
Westwood Holdings Group Inc. Reduces Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Purchased by Provident Investment Management Inc. - MarketBeat
Abbott Laboratories $ABT Shares Acquired by Public Sector Pension Investment Board - MarketBeat
Key facts: Abbott Laboratories appoints Nita Ahuja to Board; VP reports share gift - TradingView — Track All Markets
Does Abbott Laboratories (NYSE:ABT) Have A Healthy Balance Sheet? - Yahoo Finance
Curi Capital LLC Acquires 53,244 Shares of Abbott Laboratories $ABT - MarketBeat
Benjamin Edwards Inc. Has $45.44 Million Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp - MarketBeat
My Top 10 Stocks to Buy for 2026 - The Motley Fool
Ameriprise Financial Inc. Grows Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stake Boosted by Adage Capital Partners GP L.L.C. - MarketBeat
Abbott Laboratories (ABT) Expands Board of Directors with New Ap - GuruFocus
Abbott Laboratories Expands Board with New Appointment - TipRanks
Abbott Laboratories (ABT) Stock: Dividend Boost and Major Acquisition Drive 2026 Outlook - CoinCentral
Abbott Laboratories (ABT) Boosts Quarterly Dividend by 6.8% - GuruFocus
Abbott Laboratories Declares 408th Consecutive Quarterly Cash Common Dividend, Payable on February 13, 2026 - marketscreener.com
Abbott (ABT) Raises Quarterly Dividend by 6.8% - GuruFocus
Abbott Raises Quarterly Dividend to $0.63 a Share, Payable Feb. 13 to Holders of Record as of Jan. 15 - marketscreener.com
Abbott increases quarterly dividend by 6.8% for 54th consecutive year - Investing.com
Abbott increases quarterly dividend for 54th consecutive year - PR Newswire
Abbott Laboratories (ABT) Receives a Buy from Citi - The Globe and Mail
Abbott Laboratories price tries to recoup some lossesForecast today12-12-2025 - Economies.com
Assessing Abbott (ABT) Valuation After New Lingo CGM Expansion and Protein-Glucose Data Release - simplywall.st
Peapack Gladstone Financial Corp Buys 23,212 Shares of Abbott Laboratories $ABT - MarketBeat
Ieq Capital LLC Acquires 28,181 Shares of Abbott Laboratories $ABT - MarketBeat
Laird Norton Wetherby Trust Company LLC Has $7.36 Million Holdings in Abbott Laboratories $ABT - MarketBeat
Life Experiences Shape Our Work - Abbott
Technology that connects you to what matters most: Your health - Abbott
Alliancebernstein L.P. Sells 168,803 Shares of Abbott Laboratories $ABT - MarketBeat
Doing more for children’s health around the world - Abbott
Abbott Presses Congress for Shield Over Preemie Baby Formula Litigation That Could Cost It Billions - Claims Journal
Abbott Announces Its New Specialty and Metabolic Powder Nutritional Manufacturing Facility Will Be in Bowling Green, Ohio - Abbott
The Abbott World Marathon Majors - Abbott
Our People And Culture - Abbott
Responsibility - Abbott
Sustainability - Abbott
Abbott Fund - Abbott
Diagnostics Testing - Abbott
Pain and Movement - Abbott
Our Products | Full Products and Solutions List | Abbott U.S. - Abbott
Nutrition Products and Solutions | Abbott U.S. - Abbott
Medicines | Medicines, Biosimilars and Therapies in Emerging Markets | Abbott U.S. - Abbott
애보트 래버러토리스 (ABT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.90%
1.38%
자본화:
|
볼륨(24시간):